baber/WOPTO huggingface dataset:
Patent IE-48657-B1 (IE)
Title: A process for removing incrustations comprising titaniferous material from the wall of heat exchangers or reactors
IPC: C23G1/08
Filed: 1979-08-08
Abstract: A process for cleaning the walls of heat exchangers or reactors which are covered with essentially titaniferous incrustations but which can also contain silico-aluminous incrustations formed during the attack of ores and causing a considerable reduction in the heat exchange capacity, the said process being intended to restore the fundamental characteristics of the said walls, which is characterized in that the incrustations are removed by means of an aqueous treatment liquor containing from 3 to 30% by weight of hexafluosilicic acid and at most 10% by weight of hydrofluoric acid. The aqueous treatment liquor can contain a corrosion inhibitor and the treatment can be carried out at a temperature between 20 DEG C. and 80 DEG C.
Patent IE-67068-B1 (IE)
Title: A method a binder and a binding machine for closing hose or bag shaped packings primarily tubular foodstuff packings
Inventor: KROMAN FLEMMING
IPC: B65B7/02
Filed: 1987-05-26
Abstract: The closing of tubular casings containing foodstuffs by mounting a binder on a constriction of the casing involves the traditional problem of a high waste percentage due to the binders either damaging the casing material or sliding off the constriction. A method and a binder are proposed which makes it possible to obtain a very strong clamping of the binder without damaging the casing material, and, in connection with tight plastic casings, it is even possible to provide a "super tight" closure, by ranging the constriction with an oblong cross section between opposed straight clamping beams, which are forced together so as to produce a controlled deformation flowing of the casing material.
Patent IE-33603-B1 (IE)
Title: Vaccines
IPC: A61K39/35
Filed: 1969-10-20
Abstract: 1,243,832. Allergens. BEECHAM GROUP Ltd. 23 Oct., 1969 [25 Oct., 1968], No. 50645/ 68. Heading A5B. The allergenicity of an allergenic material is reduced by treating the allergenic material with a haloformate having the formula RO.CO.X wherein X is a halogen and R is alkyl, alkenyl, aryl, aralkyl, arylcarbonyl or a heterocyclic group, at a pH of from 1 to 7 and recovering the resultant modified allergenic material. The haloformate is preferably a chloroformate especially methyl, ethyl or benzoyl chloroformate. The temperature employed for the treatment is preferably about 20C. The allergenic material treated may be a protein or glycoprotein extract of the whole allergen. The allergenic material may be, or may be derived from, pollen. Pharmaceutical preparations for parenteral administration comprise the modified allergenic material and a parenterally acceptable carrier.
[GB1243832A]
Patent IE-44379-B1 (IE)
Title: Thiazolo (3,4-b)isoquinoline derivatives
IPC: A61P29/00
Filed: 1976-08-05
Abstract: 1503091 Thiazolo[3,4-b]isoquinoline derivatives RHONE-POULENC INDUSTRIES 2 Aug 1976 [6 Aug 1975 18 May 1976] 32128/76 Heading C2C Novel compounds of the Formula I wherein A is 3- or 4-pyridyl or 5-isoquinolyl and, when A is 3-pyridyl, X 1 is hydrogen, halogen, dimethylamino or cyano, X 2 is hydrogen or fluorine and X 3 is hydrogen or nitro, at least two of X 1 , X 2 and X 4 being hydrogen, or X 1 and X 2 together are methylenedioxy and X 3 is hydrogen and, when A is 4-pyridyl or 5-isoquinolyl, X 1 , X 2 and X 3 each are hydrogen, and acid addition salts thereof, may be prepared (1) when A is 3- pyridyl or 5-isoquinolyl and, when A is 3- pyridyl, X 1 is hydrogen or halogen only, by cyclizing a compound II wherein A 1 and X 4 have the limited scope of A and X 1 above and X 5 and X 6 correspond to X 2 and X 3 ; (2) provided that when A is 3-pyridyl, X 1 is hydrogen, halogen or cyano, by reacting a compound A-NH 2 with a compound VIII wherein X 7 has the limited scope of X 1 above, R 1 is chlorine, C 1-4 alkylthio or benzylthio and A 2 (-) is an anion; (3) when A is 3-pyridyl, X 3 is hydrogen and X 1 and X 2 are different and one of them is hydrogen, by reducing a nitro radical in a compound XIII wherein A 3 is 3-pyridyl and one of X 9 and X 10 is nitro and the other is hydrogen to yield a compound XIV wherein one of X 11 and X 12 is amino and the other is hydrogen, and converting the amino group to halogen, dimethylamino or cyano by known methods, optionally followed by forming an acid addition salt. Intermediates of the Formula II are prepared by reacting a 3-hydroxymethyl-1,2,3,4-tetrahydroisoquinoline with a compound A-N:C:S. Intermediates of Formula VIII wherein R 1 is chloro and A 2 (-) is chloride are prepared by reacting a 1,5,10,10a-tetrahydrothiazolo[3,4-b] isoquinoline-3-thione with phosgene. The intermediates VIII in which R 1 is methylthio and A 2 (-) is iodide are prepared by reacting the same thione with methyl iodide. 3 - Hydroxymethyl - 1,2,3,4 - tetrahydroisoquinolines appropriately substituted in the carbocyclic ring are prepared by reducing the corresponding 3 - ethoxycarbonyl - 1,2,3,4- tetrahydroisoquinoline. The separate isomers of 1,5,10,10a-tetrahydrothiazolo[3,4-b]isoquinoline-3-thione are prepared by reacting 3-hydromethyl-1,2,3,4-tetrahydroisoquinoline with sulphuric acid to yield the sulphate ester and cyclizing this by reaction with carbon disulphide in the presence of base. The corresponding 7-, 8- and 9-nitro derivatives are prepared by nitration of the sulphate ester followed by the cyclization reaction. 5 - Isothiocyanatoisoquinoline is prepared by reacting 5-aminoisoquinoline with carbon disulphide. (5) - 3 - Ethoxycarbonyl - 7 - nitro - 1,2,3,4- tetrahydroisoquinoline is prepared by nitration of the (5) - 3 - ethoxycarbonyl - 1,2,3,4- tetrahydroisoquinoline. Pharmaceutical compositions of the compounds I with the usual excipients show analgesic, antipyretic and slight anti-inflammatry activity when administered orally, parenterally, rectally or topically.
Patent IE-56585-B1 (IE)
Title: Endoprosthetic bone joint components
IPC: A61F2/00
Filed: 1985-07-31
Abstract: 57 A prosthetic component (20; 30) for replacing a region of a bone including an articular surface (12) of a joint has a first surface shaped to approximate the articular surface, and a second surface (23; 33) shaped to extend substantially perpendicularly to the principal trabecular structure (10, 11) in a section through the bone when the first surface replaces the articular surface. In the case of a long bone the second surface is preferably shaped to approximate the fused epiphyseal plate scar (15) of the bone region in question. Also the component preferably has varying elastic modulus, at least in the portion thereeof bordering the second surface, to simulate that of the bone replaced thereby.
Patent IE-51576-B1 (IE)
Title: Tetrazole derivatives
IPC: C07D409/00
Filed: 1981-08-27
Abstract: The invention relates to compounds of the general formula (I) and physiologically acceptable salts, hydrates and bio-precursors thereof in which R1 represents C1-14 alkyl, cycloalkyl, aralkyl, trifluoroalkyl, heteroalkyl, alkenyl, alkynyl, or alkyl substituted by hydroxy, alkoxy, amino, alkylamino, dialkylamino or cycloalkyl; and R2 represents hydrogen or a C1-4 alkyl group; or R1 and R2 together with the nitrogen atom to which they are attached form a 5-10 membered ring which may be saturated or may contain at least one double bond, may be unsubstituted or may be substituted by one or more C1-3 alkyl groups or a hydroxy group and/or may contain another heteroatom selected from oxygen and sulphur; Alk represents a straight or bramches C1-6 alkylene chain. Q represents a furan or thiophen ring in which incorporation into the rest of the molecule is through bonds at the 2- and 5-positions the furan or thiophen ring optionally bearing a further substituent R4 adjacent to the group R1R2N-Alkyl-; or Q represents a thiophen ring in which incorporation into the rest of the molecule is through bonds at the 2- and 4-positions, the thiophen ring optionally bearing a further substituent R4 adjacent to the group R1R2NAlk with the proviso that when the group R1R2NAlk is in the 4-position then the group R4 is in the 5-position; or Q represents a benzene ring in which incorporation into the rest of the molecule is through bonds at the 1- and 3- or 1- and 4-positions; R4 represents halogen or C1-4 alkyl which may be substituted by hydroxy or C1-4 alkoxy; R3 represents hydrogen, alkyl, alkenyl, aralkyl, C2-6 alkyl substituted by hydroxy, alkoxy, or C1-4 alkanoyloxy; X and Y, which may be the same or different, each represent oxygen, sulphur, methylene or a bond; n represents zero, 1, 2, or 3 and m represents an interger from 2 to 5 with the provisos that (a) the total number of atoms in the chain X(CH2)nY(CH2)m is an integer from 3 to 8 and (b) when X and Y represent oxygen or sulphur then n is 2 or 3. The compounds show pharmacological activity as selective histamine H2-antagonists.
Patent IE-47407-B1 (IE)
Title: Growth of biological material
IPC: C02F3/10
Filed: 1978-10-19
Abstract: A support structure for the growth of biological material from a supply of nutrient comprises one or more bodies, each of which has a substantial voidage within its internal structure and an extensive area of access from its outer surface to the internal voidage. The support structures are suitable for use in fermentation processes and the purification of sewage and industrial effluents.
Patent IE-42180-B1 (IE)
Title: Preparation of -6-deoxytetracyclines
IPC: F41A9/27
Filed: 1975-11-18
Abstract: Hydrogenation of the exocyclic methylene gp. of a 6-deoxy-6-demethyl-6-methylene-tetracycline (I), or its acid addition salt, in a stereoselective manner giving the alpha-isomer in preference to the beta-isomer, is carried out at 20-100 degrees C and 1-100 atmos. under neutral conditions, or using a weakly acidic acid addn. salt, in the presence of a catalytic amt. of a cpd. of formula Rh(OCOR)2(P C6H5 3) (II) (where R = H, 1-6C alkyl, ClCH2, Cl2CH, Cl3C, FCH2, F2CH, F3C, phenyl, chlorphenyl, tolyl, anisyl). The ratio of alpha-isomer to beta-isomer is >=9:1. Known methods give a less favourable ratio e.g. 1:1.
Patent IE-57304-B1 (IE)
Title: Endotracheal tube assembly
IPC: A61M16/04
Filed: 1983-12-14
Abstract: An endotracheal tube assembly (10) comprises an endotracheal tube (14), and an insufflation catheter (22) connectable to a source of high frequency gas and disposed in the tube. The tube has spacers (58) adjacent its distal end to space the distal end of the catheter (22) from the inner sidewalls of the tube (14). The catheter may be further provided with a suction lumen (70) for removing accumulated fluids from the trachea.
Patent IE-62594-B1 (IE)
Title: Dosage form for administering oral hypoglycemic glipizide
Inventor: KUCZYNSKI ANTHONY L
IPC: A61K9/00
Filed: 1990-08-31
Abstract: A dosage form is disclosed comprising the antidiabetic drug glipizide for administering to a patient in need of glipizide therapy.
Patent IE-62092-B1 (IE)
Title: Continuously adaptive phase locked loop synthesiz er
Inventor: HIETALA ALEXANDER W
IPC: H03L7/183
Filed: 1989-10-06
Abstract: A synthesizer is disclosed in which error correction pulses from a phase detector (205) are separated into narrow pulse width and wide pulse width pulses. The wide pulse width pulses are coupled to the loop filter (233,235,237) to enable a rapid charge of the loop filter. The narrow pulse width pulses are filtered by a narrow bandwidth filter (225,226,227) before being applied to the loop filter thus enabling a slow charge of the loop filter. The narrow bandwidth filter is decoupled from the control line but referenced to the control line voltage by a buffer amplifier (259) to preserve the adaptive nature of the loop.
Patent IE-65784-B1 (IE)
Title: (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same
Inventor: GLUCHOWSKI CHARLES
IPC: A61P1/00
Filed: 1990-10-11
Abstract: A compound selected from the group consisting of those having the formula: <CHEM> and pharmaceutically acceptable acid addition salts thereof, wherein R1 wherein R1 and R4 are independently selected from the group consisting of H and alkyl radicals containing 1 to 4 carbon atoms, R2 and R3 are independently selected from the group consisting of H, O, and alkyl radicals containing 1 to 4 carbon atoms, the 2-imidazolin-2-ylamino group may be in any of the 5-, 6-, 7- or 8- positions of the quinoxaline nucleus, and R5, R6 and R7 each is located in one of the remaining 5-, 6-, 7- or 8- positions of the quinoxaline nucleus and is selected from the group consisting of Cl, Br, H and alkyl radicals containing 1 to 3 carbon atoms. Such compounds, when administered to a mammal, provide desired therapeutic effects, such as alteration in the rate of fluid transport in the gastrointestinal tract, reduction in intraocular pressure, and increase in renal fluid flow.
Patent LU-100233-B1 (LU)
Title: Stapler having counting function
Inventor: LI ZHICONG
IPC: B25C5/16
Filed: 2017-05-16
Granted: 2017-09-27
Abstract: The present invention relates to a stapler having a counting function, including a base, the end part of the base is hinged with a staple storage chamber and a staple pressing portion; the inside of the staple storage chamber is provided with a bookbinding groove, a conveying spring is arranged in the bookbinding groove, the end part of the conveying spring is provided with a pressure sensor, the pressure sensor is connected with a controller, the controller is connected with a display screen, and the display screen is located on the surface of the staple pressing portion; the end part of the bookbinding groove is provided with a staple penetrating hole on which a non-touch counter is arranged, and the non-touch counter is connected with a controller; and the controller is connected with a buzzer alarm located inside the staple storage chamber. The present invention has the characteristics of displaying residual condition of staples, improving bookbinding quality and increasing the buffer capability of the base. Fig. 1
Patent NO-305364-B1 (NO)
Inventor: ABRAMS MICHAEL JEFFREY
IPC: C07D401/12
Filed: 1995-05-04
Abstract: PCT No. PCT/GB93/02259 Sec. 371 Date Jun. 30, 1995 Sec. 102(e) Date Jun. 30, 1995 PCT Filed Nov. 3, 1993 PCT Pub. No. WO94/10149 PCT Pub. Date May 11, 1994A compound of formula I    <IMAGE>  (I)  in which E is an alkenyl group or represents H2 in which case the compound is in acid addition salt form, J is selected from -CO-NH-, -CO-O-, -CO-S- and -NH-CO-, T is an alkylene chain, or, if J is -CO-NH-, T is the residue of an amino acid moiety, Q is a hydrophilic or cleavable moiety, and Z is an amine- and/or thiol-reactive moiety. Conjugates formed by reacting such compound with a macromolecule, e.g. an immunoglobulin, and labelled macromolecules comprising a metal atom bound to such conjugate are also disclosed.
Patent NO-310806-B1 (NO)
Inventor: BLANCHE PAUL
IPC: B01D33/067
Filed: 1995-08-11
Abstract: A means separates solid matter from liquid and includes a perforated separation panel through which the liquid can pass and which prevents the passage of the solid matter of a size larger than a predetermined size. When solid matter becomes located against the panel, the flow of liquid along the face of the panel on which the solid matter is located will tend to cause the solid matter to move from the panel so that the panel is self cleaned and does not become obstructed by the solid matter.
Patent NO-315252-B1 (NO)
Inventor: PAGEAT PATRIK
IPC: A01N37/06
Filed: 1996-09-10
Abstract: A composition containing an emulsion comprising a mixture of fatty acids or derivatives thereof and a compound of vegetal origin that has an attractive effect on cats. This composition can be utilized in a process for preventing cats from urinating a marked spot or to prevent anxiety in cats or to familiarize cats placed in a new environment.
Patent NO-310936-B1 (NO)
Inventor: BOISSONNAT PHILIPPE
IPC: C03C25/26
Filed: 1997-01-16
Abstract: PCT No. PCT/FR96/00851 Sec. 371 Date Mar. 25, 1997 Sec. 102(e) Date Mar. 25, 1997 PCT Filed Jun. 6, 1996 PCT Pub. No. WO96/41912 PCT Pub. Date Dec. 27, 1996Composite yarn comprising an intimate mixture of glass filaments and thermoplastic filaments, wherein said composite yarn is coated with an aqueous sizing composition containing at least one additive in the form of a fatty acid ester; and the aqueous sizing composition per se.
Patent NO-312969-B1 (NO)
Title: Peroksidblandinger for herding av polymerer
Inventor: ABRIGO LUCIANO
IPC: C08F4/34
Filed: 1999-12-14
Abstract: Blandinger for polymerherding, omfattende. a) ett eller flere organiske peroksider med generell formel: R'-C(CH)-00-C(CH)-R, hvor Rer alkyl-, aryl- eller aryl-alkyl-substituert gruppe med 1-9 karbonatomer; Rer fenylen, etylen, -C=C-, alkyl-, aryl- eller aryl-alkyl-substituerte gruppe med 1-9 karbonatomer, og n er 1 eller 2, eller. hvor Rer alkyl-, aryl- eller aryl-alkyl-substituert. gruppe med 1-9 karbonatomer, R4 og Rer lineære eller forgrenede alkylgrupper med 1-6 karbonatomer, eller -(CH)-C(0)OR, hvor R5 er en alkylgruppe med 1-4 karbonatomer og m er 1, 2 eller 3, eller de danner en sykloheksan- eller syklododekan-ring med 1-3 alkylgrupper med 1-4 karbonatomer, og. >b) 3,7-dimetyl-l,3,6-oktatrien (OCIMENE).
Patent AT-509078-B1 (AT)
Title: Verfahren zur evakuierung von hohlräumen
Inventor: SCHWAIGER MEINHARD DIPL ING
IPC: E06B3/263
Filed: 2010-01-26
Granted: 2011-06-15
Abstract: Die Erfindung betrifft ein Verfahren und eine Vorrichtung zur Evakuierung von Hohlräumen, insbesondere von Hohlkammern (1'', 1''', 1'''') von Kunststofffenstem, bei dem eine Öffnung (16) in einer Außenwand (18) der Hohlkammer (1'', 1''', 1'''') geschaffen wird, Luft aus der Hohlkammer (1'', 1''', 1'''') abgesaugt wird und danach die Öffnung (16) verschlossen wird. Eine verbesserte Isolationswirkung wird dadurch erreicht, dass die Öffnung (16) durch einen Saugrüssel (8) abgeschlossen wird und unmittelbar nach dem Absaugen der Luft ein Verschluss (2) auf die Öffnung (16) aufgebracht wird, um diese zu verschließen.
Patent AT-512815-B1 (AT)
Title: Luftleitvorrichtung für eine Heizeinrichtung
Inventor: RIENER KARL STEFAN
IPC: F02M29/14
Filed: 2012-04-27
Granted: 2014-02-15
Abstract: Die Erfindung betrifft eine Luftleitvorrichtung (22) für eine Heizeinrichtung (1) umfassend ein Gehäuse (3) mit einer Brennraumtür (6), einen über die Brennraumtür (6) zugänglichen Brennraum (2) und zumindest eine Auslassöffnung (18, 19, 20) im Brennraum (2), über die ein Luftzuleitungskanal derart mit dem Brennraum (2) verbunden ist, dass eine zugeführte Luft an einer Innenseite (28) einer Sichtscheibe (7) in der Brennraumtür (6) entlangströmt. Wesentlich ist dabei, dass die aus einem luftundurchlässigen Material, insbesondere Metall, gebildete Luftleitvorrichtung (22) anschließend an die zumindest eine Auslassöffnung (18,19, 20) im Brennraum (2) angeordnet ist und die zugeführte Luft (23) an einer ebenen Vorderseite (24) der Luftleitvorrichtung (22) entlangströmt, welche Vorderseite (24) Vorsprünge (25) in Art von Noppen aufweist. Dadurch ist eine Luftleitvorrichtung (22) für eine Heizeinrichtung (1) geschaffen, welche die Zufuhr von Spülluft an die Innenseite (28) der Sichtscheibe (7) der Heizeinrichtung (1) verbessert, sodass eine Ablagerung von Verbrennungsrückständen an der Innenseite (28) der Sichtscheibe (7), insbesondere auch nach einer längeren Betriebsdauer, praktisch ausgeschlossen ist.
Patent BR-0305199-B1 (BR)
Inventor: JANSEN HELGE
IPC: C04B14/34
Filed: 2003-11-13
Abstract: Refractory repairing composition comprises a refractory, especially basic, resistor component in granulate form, and a binder system containing a hard bitumen component in granulate form, an ignitable metal powder and a combustible mineral oil.  An Independent claim is also included for a process for the production of a refractory repairing composition.
Patent BR-PI9816272-B1 (BR)
Title: processo de filtragem adaptativo de sinal, processo de filtragem de dado de imagem, e aparelho de filtragem de dado de imagem
Inventor: PARK HYUN-WOOK
IPC: H04N19/159
Filed: 1998-06-18
Abstract: processo de filtragem de dado de imagem, e aparelho de filtragem de dados de imagem.<um> pedido divisional do pedido de patente nº pi9811111-6 de 18.06.98.<mv> processo de filtragem adaptativo de sinal para redução de efeito de bloqueio e ruido de chamada, um filtro adaptativo de sinal, e um mecanismo de leitura por computador. o processo de filtragem adaptativo de sinal capaz de reduzir o efeito de bloqueio e ruído de chamada do dado de imagem quando um quadro é composto de blocos de um tamanho pré-determinado inclui as etapas de: (a) geração de informação de bloqueio para redução do efeito de bloqueio e informação de chamada para redução do ruído de chamada, a partir de coeficientes de pixéis pré-determinados das regiões de limite superior e esquerdo do bloco de dados quando um quadro obtido pela desconstrução de um dado de imagem de fluxo de bits por quantização inversa for um quadro intra; e (b) filtragem de forma adaptativa do quadro de imagem passado através de quantização inversa e transformada inversa discreta de coseno de acordo com as informações de bloqueio e chamada geradas. portanto, o efeito de bloqueio e ruído de chamada podem ser eliminados da imagem restaurada a partir da imagem baseada em bloco, acentuando assim a imagem restaurada a partir da compressão.
Patent BR-PI9907910-B1 (BR)
Title: máquina elétrica rotativa
Inventor: AKEMAKOU DOKOU ANTOINE
IPC: H02K1/27
Filed: 1999-12-17
Abstract: ''máquina elétrica rotativa''. uma máquina elétrica rotativa compreende um estator (10) equipado com bobinas de induzido (18) e um rotor (20) montado rotativo no interior do estator, o rotor possuindo uma série de ímãs (22n, 22s) de polaridades alternadas avizinhados por partes magnéticas com relutância (24a, 24b) associadas respectivamente aos ditos ímãs, cada conjunto de um imã e de uma parte magnética associada definindo um pólo (pp) de rotor. de acordo com a invenção, pelo menos alguns dos ditos pólos possuem alternativamente, de acordo com uma direção geralmente tangencial, um ímã (22s) seguido por sua parte magnética (24a) e um ímã (22n) precedido por sua parte magnética (24b). aplicação notadamente aos alternadores e alternadores-motores de arranque de veículos automóveis.
Patent BR-9917526-B1 (BR)
Inventor: KHATRI GHAN SHYAM
IPC: A61P31/04
Filed: 1999-10-19
Abstract: A portion of the lysostaphin gene of Staphylococcus simulans has been cloned and overexpressed in the cytoplasm of E. coli to yield lysostaphin, in the absence of preprolysostaphin and prolysostaphin, under the transcriptional control of an IPTG-inducible promoter and a ribosome binding site. IPTG induction of the transformed host cells produces intracellular, soluble, mature lysostaphin (27 kDa), in the complete absence of preprolysostaphin and prolysostaphin. The mature lysostaphin so formed dose not require post-translational modification. The mature lysostaphin so formed can be used treat and prevent staphylococcal infections.